Insider Trading March 23, 2026

CNO Financial Insider Executes Option Exercise and Disposes of Shares Worth $879k

President of Consumer Division sells 22,120 shares under a 10b5-1 plan while simultaneously exercising options to acquire the same number of shares

By Priya Menon CNO
CNO Financial Insider Executes Option Exercise and Disposes of Shares Worth $879k
CNO

Scott L. Goldberg, President of the Consumer Division at CNO Financial Group, sold 22,120 shares of common stock on March 19 and 20, 2026, under a Rule 10b5-1 plan and concurrently exercised options to buy 22,120 shares at $21.06 per share. The transactions occurred against a backdrop of mixed fourth-quarter 2025 results for CNO, with revenue beating expectations but EPS missing forecasts.

Key Points

  • Scott L. Goldberg sold 22,120 CNO shares on March 19 and 20, 2026 for approximately $879,423, at prices from $39.543 to $39.9709.
  • Goldberg exercised options to acquire 22,120 shares at $21.06 per share on the same dates, costing $465,847 in total; the sales were executed under a Rule 10b5-1 plan adopted on November 6, 2025.
  • CNO reported mixed fourth-quarter 2025 results: EPS of $0.95 missed the $1.21 forecast while revenue of $1.14 billion beat the $1.00 billion estimate; the stock trades at $40.54 with a $3.83 billion market cap and a P/E of 17.69.

Scott L. Goldberg, who serves as President of the Consumer Division at CNO Financial Group, Inc. (NYSE:CNO), completed a set of linked equity transactions on March 19 and 20, 2026. Over those two days Goldberg sold 22,120 shares of CNO common stock for aggregate proceeds of approximately $879,423.

The disposal occurred across pricing that ranged from $39.543 to $39.9709 per share. Concurrent with the sales, Goldberg exercised options to acquire 22,120 shares of CNO common stock at an exercise price of $21.06 per share, representing a cash outlay of $465,847 to acquire the shares through option exercise.

Company filings state the sales were carried out pursuant to a Rule 10b5-1 trading plan established on November 6, 2025. That pre-arranged plan governed the timing and execution of the share disposals reported on March 19 and 20, 2026.

At the time of reporting, CNO shares traded at $40.54, and the company had a market capitalization of $3.83 billion with a price-to-earnings ratio of 17.69. Analysis by InvestingPro places the stock among issues that appear undervalued relative to their Fair Value and lists the name on a Most Undervalued stocks compilation. InvestingPro Tips additionally note a 1.71% dividend yield for CNO and record that the company has raised its dividend for 14 consecutive years, alongside seven other investor-focused insights highlighted by that service.

These insider transactions come after the company released fourth-quarter 2025 financial results that presented a mixed picture. CNO reported earnings per share of $0.95, below the consensus expectation of $1.21. At the same time, the company recorded revenue of $1.14 billion, outperforming the anticipated $1.00 billion. Market commentary referenced resilience in the stock during after-hours trading following the results.

The juxtaposition of an insider executing option exercises while selling an equivalent number of shares under a pre-arranged plan, together with the mixed quarterly results, frames the recent activity. Investors and analysts will continue to monitor how the company reconciles the EPS shortfall with top-line strength going forward.


Contextual note - The transactions, market data, dividend details and quarterly results in this report reflect the facts disclosed in company filings and the InvestingPro analysis cited; no additional assumptions or extrapolations have been made.

Risks

  • Earnings uncertainty - the company posted fourth-quarter 2025 EPS of $0.95, short of the $1.21 consensus, creating near-term earnings risk for investors in the insurance and financial services sector.
  • Market reaction to mixed results - despite revenue exceeding expectations, mixed financial outcomes could lead to continued volatility in CNO shares in equity markets.
  • Insider activity interpretation - insider option exercises coupled with share sales under a pre-arranged 10b5-1 plan may raise questions among shareholders about timing and personal liquidity needs, affecting investor sentiment in the financial services sector.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026